UNSPSC 85494430: Replacement of left pulmonary vein with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left pulmonary vein with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02RT0JZ

UNSPSC 85494430 Replacement of left pulmonary vein with synthetic substitute, open approach is a Commodity code whose title reflects a specific surgical procedure, but recent state and local procurement activity under this code shows no alignment with that clinical scope. The source contains no opportunities for surgical implants, vascular prosthetics, or replacement grafts. Instead, the recent solicitations tagged under this code cover independent medical evaluation services, occupational health surveillance, pharmacy benefit management, specialty surgical network carve-outs, temporary health professional staffing, and emergency medical services for youth in custody—none of which involve the procurement or implantation of synthetic vascular substitutes. This represents a cataloging mismatch rather than a genuine commodity family in active state and local procurement.

The geographic and issuing-body spread across the six recent opportunities spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County). The jurisdictions range from state departments and county boards to municipal governments and health systems. No single issuer or state dominates the activity, and the opportunities themselves—response dates from late August through mid-October 2026, contract values ranging from unspecified RFI responses to an $8.7 million annual pharmacy spend—are grounded in health administration, workforce management, and benefits services rather than medical device or surgical supply procurement. This code presents no relevant buying signal for vendors in the medical device, surgical implant, or vascular prosthetic sectors.